RT Journal Article
SR Electronic
T1 Current and Lifetime Somatic Symptom Burden Among Transition-aged Autistic Young Adults
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.02.21264461
DO 10.1101/2021.10.02.21264461
A1 Williams, Zachary J.
A1 Gotham, Katherine O.
YR 2021
UL http://medrxiv.org/content/early/2021/10/03/2021.10.02.21264461.1.abstract
AB Background and Objectives Somatic symptoms are the most common cause of outpatient medical visits in the general population, yet their presence and severity in individuals on the autism spectrum has rarely been studied. We sought to assess the prevalence, impact, and clinical correlates of fourteen commonly-reported somatic symptoms in a sample of transition-aged autistic young adults.Methods A sample of 290 independent and cognitively able autistic young adults (aged 18–26 years; mean [SD]: 23.10 [2.38] years) was recruited from the Simons Foundation SPARK participant pool. A modified version of the Patient Health Questionnaire–15 was used to assess somatic symptom prevalence/impact, along with measures of depression, anxiety, autistic traits, and quality of life.Results Somatic symptom burden was much higher in autistic young adults than previously reported in the general population. The most commonly reported current symptoms were fatigue (72.8%), sleep problems (69.0%), and menstrual problems (61.4% of females). Moderate or severe symptom levels were reported by 53.9% of females and 18.75% of males in our cohort, with the odds of females of endorsing any given symptom being 2–4 times greater than males. Both individual symptoms and total symptom burden were related to higher levels of depression, anxiety, and autistic traits, along with lower quality of life.Conclusion Despite little research on this topic previously, somatic symptoms are highly prevalent in autistic young adults, particularly women. Future research is needed to investigate links between somatic symptoms, medical and psychiatric morbidity, and health care utilization in the autistic population.What’s Known on This Subject Somatic symptoms are highly prevalent in the general population and account for a large proportion of health care costs. However, few studies have investigated the prevalence, impact, or correlates of these symptoms in individuals on the autism spectrum.What This Study Adds To our knowledge, this is the first study to specifically assess current and lifetime somatic symptom burden, symptom onset patterns, and the clinical correlates of multisystem symptom distress in transition-aged young adults on the autism spectrum.Competing Interest StatementZJW has received consulting fees from Roche. He also serves as a family partner of the Autism Speaks Autism Care Network and a member of the Autistic Researchers Review Board of the Autism Intervention Research Network on Physical Health (AIR-P). KOG declares no competing interests.Funding StatementThis study was supported by National Institute of Mental Health grant R01-MH113576 (KOG), National Institute on Deafness and Other Communication Disorders grant F30-DC019510 (ZJW), National Institute of General Medical Sciences grant T32-GM007347 (ZJW), and the Nancy Lurie Marks Family Foundation (ZJW).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All study procedures were approved by the institutional review board at Vanderbilt University Medical Center.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesApproved researchers can obtain the SPARK population dataset described in this study (project number RM0030Gotham) by applying at https://base.sfari.org. BDI-IIBeck Depression Inventory–IIGAD-7Generalized Anxiety Disorder–7M-PHQModified version of the Patient Health Questionnaire–15PHQ-15Patient Health Questionnaire–15QoLQuality of LifeSPARKSimons Powering Autism Research KnowledgeSRS-2Social Responsiveness Scale–Second EditionWHOQOL-4World Health Organization Quality of Life–4 item scale